$DIM #Sartorius Stedim Biotech Sartorius Stedim Biotech : Q1 2020 sales/EBITDA beat our expectations, guidance raised, target price lifted to € 202: &gt;Q1 2020: robust sales, backlog and margin - SSB reported € 422.1m in Q1 sales (+23.1%… https://t.co/fDZx8gXxC8 #equity #stocks https://t.co/wz0ibKRMT7